A strongly moving lung target is a relative contraindication to a particular proton therapy plan if respiratory motion and changing air–tissue paths make robust target coverage and normal-tissue constraints unattainable. A changing water-equivalent path changes the particle range; pencil-beam scanning can also interact with respiratory motion. A photon radiotherapy plan may then offer more reliable coverage despite its greater exit dose. This is a conditional planning contraindication, not a blanket claim that lung cancer cannot be treated with protons: gating, breath-hold, rescanning and adaptive planning can change the decision. If a robust comparative plan shows no meaningful benefit, the additional cost and access burden also weigh against the proton plan.[ref]
Respiratory motion management for particle therapy by AAPM. Report 290, dose uncertainty from respiratory motion and need for site-specific planning studies
Ancestors (12)
- b
- 3
- S10
- 2019
- Past exam of the short options paper shared by Parts A and B of the physics course of the University of Oxford
- Short options paper shared by Parts A and B of the physics course of the University of Oxford
- Physics course of the University of Oxford
- Undergraduate course of the University of Oxford
- Course of the University of Oxford
- University of Oxford
- List of universities
- Home
Discussion (0)
New discussionThere are no discussions about this article yet.
Articles by others on the same topic (0)
There are currently no matching articles.